Co-opting Weight Stigma
The relentless push for weight loss drugs, particularly by Novo Nordisk, is infiltrating media narratives and grassroots movements. Experts quoted in major publications often have undisclosed financial ties to these companies, raising ethical concerns about the integrity of the discourse. This manipulation extends to co-opting anti-weight stigma efforts, framing access to these drugs as the solution to stigma while sidelining genuine advocacy.In this clip
From this podcast
Rethinking Wellness
The Dangers of Diet Drugs: Behind the GLP-1 Weight-Loss Hype with Ragen Chastain
Related Questions
Does health insurance cover weight loss programs like those discussed in the episode The Science and Supply of GLP-1s with Chronis Manolis and the clip Medicare Coverage Changes?
Does health insurance cover weight loss programs as discussed in the episode The Science and Supply of GLP-1s with Chronis Manolis and the clip Medicare Coverage Changes?